"OssDsign® Spine Registry Study (Propel)"

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

March 23, 2027

Study Completion Date

April 1, 2027

Conditions
Degenerative Disc DiseaseSpinal Stenosis
Interventions
DEVICE

OssDsign® Catalyst

An osteoconductive, resorbable, porous, 100 % nano synthetic calcium phosphate bone void filler

Trial Locations (13)

16801

RECRUITING

University Orthopedics Center, State College

20817

ACTIVE_NOT_RECRUITING

OrthoBethesda Research Foundation, Bethesda

30501

ACTIVE_NOT_RECRUITING

Northeast Georgia Medical Center, Gainesville

33133

RECRUITING

Minimally Invasive Spine Center of South Florida, Miami

33607

RECRUITING

Foundation for Orthopaedic Research and Education, Tampa

42001

ACTIVE_NOT_RECRUITING

Orthopaedic Institute of Western Kentucky, Paducah

55435

RECRUITING

Twin Cities Orthopedics, Edina

61801

ACTIVE_NOT_RECRUITING

Carle Foundation Hospital, NeuroScience Institute, Urbana

92024

TERMINATED

San Diego Neurosurgery, San Diego

93720

RECRUITING

Community Health Partners Neuroscience, Fresno

06102

ACTIVE_NOT_RECRUITING

Orthopedic Associates of Hartford, Hartford

06051

RECRUITING

Central Connecticut Neurosurgery and Spine, New Britian

06519

RECRUITING

Yale Center for Clinical Investigation, Yale School of Medicine, New Haven

All Listed Sponsors
lead

OssDsign

INDUSTRY